Antacids: all 1,673 studies that test it
Page 13 of 17. Open to participants first (138), then studies with results posted, then the rest; newest registration first within each.
- Vitamin D, Cardiovascular Disease, and African AmericansCompletedNCT01655810Not applicable
- Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed StudyCompletedNCT01654718Not applicable
- Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fasting StudyCompletedNCT01654705Not applicable
- Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest PainWithdrawnNCT01637571Phase 4
- Efficacy and Safety of Rebamipide in Subjects With Dry Eye SyndromeCompletedNCT01632137Phase 3
- A Randomized, Double-Blind, Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 (20 mg, 40 mg) in Patients With Proton Pump Inhibitor (PPI) - Resistant Erosive EsophagitisCompletedNCT01630746Phase 3
- Intravaginal Misoprostol Versus Dinoprostone Before Diagnostik HysteroscopyStatus unknownNCT01620814Phase 4
- Repeated Doses of Misoprostol for Medical Treatment of Missed MiscarriageTerminatedNCT01615224Phase 2/3
- Combined Therapy in Radiation ProctopathyCompletedNCT01613534Phase 4
- Optimum Misoprostol Dose Prior to Office HysteroscopyCompletedNCT01612065Phase 3
- The Efficacy of Pantoprazole Treatment in Patients With Functional DyspepsiaStatus unknownNCT01608750Phase 4
- Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy 10 Days in the First Line TherapyStatus unknownNCT01607918Phase 4
- Effect of Single Doses of YF476 on Stomach AcidityCompletedNCT01601418Phase 1
- Effect of Repeated Doses of YF476 on Stomach AcidityCompletedNCT01601405Phase 1
- Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized TrialStatus unknownNCT01600612Not applicable
- Effect of Repeated Doses of YF476, Omeprazole and Placebo on Stomach Acidity in Healthy VolunteersCompletedNCT01599858Phase 1
- Effect of 5, 10 or 25 mg of YF476 Daily for 14 Days on Stomach Acidity in Healthy VolunteersCompletedNCT01597674Phase 1
- Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid TumorsCompletedNCT01596647Phase 1
- The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic UlcersCompletedNCT01591083Phase 4
- The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated OphthalmopathyCompletedNCT01579539Phase 3
- Role of Calcium And Vitamin D In Nutritional Rickets And It's ManagementCompletedNCT01578434Phase 4
- Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple TherapyStatus unknownNCT01572597Phase 4
- Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean SectionCompletedNCT01571323Phase 1/2
- A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin TherapyCompletedNCT01568398Phase 3
- A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) TherapyCompletedNCT01568385Phase 3
- The Pharmacokinetic Interaction Between Celecoxib and RebamipideCompletedNCT01549743Phase 1
- Drug Drug Interaction Study Of Crizotinib With Esomeprazole.CompletedNCT01549574Phase 1
- Research for Prevention and Treatment of NSAIDs Related Gastrointestinal Side EffectsStatus unknownNCT01547559Not applicable
- Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of VandetanibCompletedNCT01539655Phase 1
- Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion in NigeriaCompletedNCT01539408Phase 1
- Effect of Single Doses of YF476 on Stomach Acidity Compared With Ranitidine and Placebo in Fasted and Fed StatesCompletedNCT01538797Phase 1
- Safety, Tolerability and Pharmacokinetics of Single Rising Doses of YF476, a Gastrin Antagonist, in Healthy MenCompletedNCT01538784Phase 1
- Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line TherapyStatus unknownNCT01537055Phase 4
- Dexpramipexole and Cimetidine Drug Drug Interaction (DDI)CompletedNCT01536249Phase 1
- Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary HemochromatosisStatus unknownNCT01524757Not applicable
- Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer SubjectsCompletedNCT01517399Phase 1
- New Dual Therapy for Primary Treatment of Helicobacter Pylori Infection：a Pilot StudyCompletedNCT01513785Phase 2
- Bioavailability Study of Famotidine Tablets 40 mg Under Fasting ConditionsCompletedNCT01511731Phase 1
- A Study of Self-administered Misoprostol to Prevent Bleeding After Childbirth in the Community (MamaMiso)CompletedNCT01510574Not applicable
- Efficacy Study of Ilaprazole to Treat Erosive EsophgitisCompletedNCT01509261Phase 3
- Misoprostol for Treatment of Postpartum Haemorrhage (PPH) in Home BirthsCompletedNCT01508429Not applicable
- Comparitive Study of Two Misoprostol Regimen in Early Pregnancy TerminationCompletedNCT01508143Not applicable
- Helicobacter Eradication Aspirin TrialCompletedNCT01506986Phase 4
- Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. PyloriCompletedNCT01505127Phase 3
- Magnesium Pantoprazole 20mg b.i.d. vs Magnesium Pantoprazole 40mg q.d. on Intragastric Acid InhibitionWithdrawnNCT01499693Phase 3
- Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male SubjectsCompletedNCT01494402Phase 1
- Comparing Misoprostol and Oxytocin in UnijectTM for Postpartum Hemorrhage (PPH) Prevention in MaliWithdrawnNCT01487278Not applicable
- Treatment of Postpartum Haemorrhage (PPH) Using Misoprostol in Home BirthsCompletedNCT01485562Not applicable
- Efficacy and Safety of Split-dose Citrafleet Administered From 2 to 6 Hours Before Morning ColonoscopiesStatus unknownNCT01481714Phase 4
- Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic EsophagitisWithdrawnNCT01479231Phase 1/2
- Comparative of Effects of Sublingual Misoprostol and Infusion Oxytocin in Reduction of Bleeding at CesareanStatus unknownNCT01477840Phase 2/3
- Study on Combined Use of Letrozole, Mifepristone and Misoprostol in Termination of PregnancyStatus unknownNCT01475318Not applicable
- Efficacy of TAK-438 Compared to Placebo in the Treatment of Non-Erosive Gastroesophageal Reflux DiseaseCompletedNCT01474369Phase 3
- Safety, Tolerability, PK, PD of Escalating Single and Multiple Oral Doses of CJ-12420 in Healthy Male SubjectsCompletedNCT01473173Phase 1
- Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBICWithdrawnNCT01471925Phase 3
- Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO)CompletedNCT01470690Phase 1
- Sublingual Misoprostol & Isoflurane During Caesarean SectionCompletedNCT01466530Phase 2
- Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in IndiaCompletedNCT01462422Not applicable
- Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive EsophagitisCompletedNCT01459367Phase 3
- Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)CompletedNCT01456260Phase 3
- Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose AspirinCompletedNCT01456247Phase 3
- Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive EsophagitisCompletedNCT01452776Phase 3
- Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose AspirinCompletedNCT01452763Phase 3
- Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)CompletedNCT01452750Phase 3
- Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal UlcerCompletedNCT01452724Phase 3
- Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric UlcerCompletedNCT01452711Phase 3
- Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive EsophagitisCompletedNCT01452698Phase 3
- YF476 and Type I Gastric Carcinoids (Norway)TerminatedNCT01444014Phase 2
- Safety and Efficacy Study of Vaginal Misoprostol for Cervical Ripening and Induction of LaborCompletedNCT01428037Phase 3
- Compare the Pharmacokinetics of Omeprazole, Rosiglitazone, and Desipramine When Administered With Avanafil in Healthy Male SubjectsCompletedNCT01415128Phase 1
- Control of Blood Loss During Caesarean SectionCompletedNCT01412073Phase 3
- ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASACompletedNCT01408186Phase 3
- Sublingual Misoprostol for Induction of LaborCompletedNCT01406392Phase 4
- Effects of Gastric pH on the Pharmacokinetics of DasatinibCompletedNCT01398046Phase 1
- A Study to Evaluate The Effects of Two Different Meal Types, Omeprazole And Ranitidine On Danoprevir Pharmacokinetics When Coadministered With Ritonavir in Healthy VolunteersCompletedNCT01392755Phase 1
- Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERDWithdrawnNCT01391715Phase 3
- Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese SubjectsCompletedNCT01390714Phase 1
- Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine StudyWithdrawnNCT01376765Phase 1
- Prevention of Postpartum Haemorrhage With Sublingual Misoprostol or OxytocinCompletedNCT01373359Phase 3
- Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult VolunteersCompletedNCT01358383Phase 1
- BRAVO Study for Functional DyspepsiaCompletedNCT01349413Phase 4
- YF476 and Type I Gastric CarcinoidsCompletedNCT01339169Phase 2
- A Study to Compare Omeprazole Administered as Zegerid® Powder and as Prilosec® Capsule in Healthy Participants (P08050)(CL2010-12)CompletedNCT01337804Phase 1
- Tepilta® Versus Oxetacaine, Antacids and PlaceboTerminatedNCT01336530Phase 3
- H. Pylori Eradication Using Pyklear in Adults in El Paso, Texas: a Pilot StudyStatus unknownNCT01335334Phase 4
- Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil HypertrophyStatus unknownNCT01328652Phase 4
- Evaluating Treatment Response in Laryngo-Pharyngeal RefluxWithdrawnNCT01328392Not applicable
- Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal DissectionStatus unknownNCT01308177Phase 4
- Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori EradicationCompletedNCT01306786Not applicable
- BAY73-4506 Probe Substrate StudyCompletedNCT01287598Phase 1
- A 3-Part Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0980, the Effect of Food, and the Effect of Rabeprazole on the Pharmacokinetics of the TabletCompletedNCT01287091Phase 1
- Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fed ConditionCompletedNCT01283932Phase 1
- Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fasting ConditionCompletedNCT01283919Phase 1
- CLL Empirical Antibiotic RegimenCompletedNCT01279252Phase 2
- A Double Blind Study Comparing Two Doses of IV Esomeprazole After Successful Endoscopic TherapyStatus unknownNCT01275937Phase 4
- Pharmacokinetics of Misoprostol With Titrated Oral AdministrationCompletedNCT01271257Phase 1
- Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting ConditionsCompletedNCT01270308Phase 1
- Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical TrialCompletedNCT01269788Phase 2/3
- Impact of Omeprazole and Fluvoxamine on Platelet Response to ClopidogrelCompletedNCT01269333Phase 1
- A Bioequivalence Study of 2 Formulations of Rabeprazole Sodium and Evaluation of the Effect of Food on Rabeprazole Sodium in Healthy Adult VolunteersCompletedNCT01241409Phase 1